High Tower Advisors, LLC Genprex, Inc. Put Options Transaction History

High Tower Advisors, LLC

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2021 Feb 10, 2022	SELL	$1.21 - $2.7 $33,880 - $75,600	-28,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.59 - $3.36 $72,520 - $94,080	28,000 New	28,000 $18,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.